The Pharmacological Profile of Cyclin-dependent Kinase (CDK) 4/6 Inhibitors: Clinical Management of Toxicity and Drug Interactions Related to CDK 4/6 Inhibitor-based Treatment in Advanced/Metastatic Breast Cancer

Categoría del artículo: Review Article

Publicado en línea: 05 abr 2020

Páginas: 2 - 14

Recibido: 12 may 2019

Aceptado: 07 oct 2019

DOI: https://doi.org/10.2478/fco-2019-0007

Palabras clave

Breast cancer, CDK4/6 inhibitors, toxicity, drug interactions, clinical management

© 2019 Tzelepi C. Vasiliki et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.